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Abstract
Background and Aim: Diarrhea and acute gastroenteritis are among the leading causes of
illnesses and death in infants and children throughout the world, especially in developing
countries, Globally, Salmonella and Shigella remain the major contributors to acute enteric
infections and diarrhea.
Methods: In the present study, Shigella- and Salmonella-related diarrhea was studied
among 3570 children in Gaza, Palestine from January 1999 to September 2006 to deter-
mine the prevalence and the antimicrobial susceptibility of the isolates.
Results: The frequency of isolation was 1.8% (65/3570) for Salmonella spp. and 0.8%
(28/3570) for Shigella spp. Shigella flexneri (16/28) was the most frequently isolated
Shigella species. Most of the Shigella isolates were resistant to trimethoprim-
sulfamethoxazole (89%), ampicillin (79%) and chloramphenicol (46%) and most of the
Salmonella isolates showed resistance to ampicillin (62%), trimethoprim-sulfamethoxazole
(35%), chloramphenicol (35%) and cephalexin (26%).
Conclusion: These data reinforce the need for continuous monitoring of microbiological
and antimicrobial surveillance and the necessity to regulate the use of antimicrobials.
According to the current study, ampicillin, trimethoprim-sulfamethoxazole and chloram-
phenicol should not be used as empiric treatment of diarrhea in children.
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Introduction
Diarrhea and acute gastroenteritis are among the leading causes of
illness and death in infants and children throughout the world,
especially in developing countries. This is so in Asia, Africa and
Latin America, where an estimated 2.5 million deaths occur each
year in children, resulting in over a quarter of all childhood
deaths.1,2 In Palestine about 49.4% of the population in Gaza Strip
is under 15 years old.3,4 Diarrhea is one of the major causes of
many outpatient visits and hospitalizations in Gaza Strip.5 Glo-
bally, Salmonella and Shigella remain the major contributors to
acute enteric infections and diarrhea. The common route of infec-
tion by these pathogens is the ingestion of contaminated foods and
drinks.6
Antimicrobial resistance among the major bacterial causes of
diarrhea is increasing worldwide. Although initially susceptible
to many antimicrobial agents, Shigella and Salmonella isolates
resistant to multiple agents have been reported.7 Since the 1960s,
various Salmonella spp. resistant to ampicillin, chloramphenicol
and trimethoprim-sulfamethoxazole have been reported with
increasing frequency through out the world.8 Over the past
several decades, strains of Shigella spp. have progressively
become resistant to most of the widely used and inexpensive
antimicrobials.9
Antibiotic therapy is not appropriate in the management of
simple gastroenteritis even when a bacterial cause is suspected
because most cases of acute diarrhea are of viral etiology or
self-limited. Despite this, a recent multicenter study from Europe
showed that 44% of physicians would use antibiotics.10 Antibiotics
are recommended for treating bloody diarrhea to shorten the dura-
tion of illness, decrease morbidity and mortality and reduce the
duration of bacterial shedding.11,12
In Palestine, most hospitals and clinics treat diarrhea-infected
patients with antibiotics prior to receiving definitive laboratory
results. For the empiric treatment of diarrheal infections in Gaza
Strip, ampicillin and trimethoprim-sulfamethoxazole are most
often used. Quinolones are not commonly used for the treatment of
diarrheal infections in children because they are expensive and
contraindicated for children, and have been associated with
adverse effects on cartilage and bone growth in animals.6
As a result of these concerns, the aim of the present study was
to explore developing trends and patterns of resistance to 11 anti-
microbial agents used for the treatment of patients with Salmo-
nella and Shigella isolates related to diarrhea in Palestine. The
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changing resistance indicates the need for continuous monitoring
of antibiotic resistance in order to update the recommendations
for empiric antibiotic therapy of suspected shigellosis and
salmonellosis.
Methods
Study population and sample collection
We evaluated 3570 stool specimens submitted from January 1999
to September 2006 to the Laboratory of Clinical Microbiology at
ElNasser pediatric hospital, Gaza, Palestine. This hospital is the
largest pediatric hospital in Palestine.
All stool samples were examined for the presence of Salmo-
nella and Shigella over the course of this study. All studied patients
ranged in age from 1 month to 12 years. After collection with the
help of the patients’ parents, stool specimens were transferred
within 1 h to the laboratory for analysis. The reasons all children
enrolled in this study attended the hospital for examination (hos-
pitalized patients) were: (i) diarrhea only; (ii) diarrhea with vom-
iting; (iii) diarrhea and fever; (iv) diarrhea together with vomiting
and fever. In some cases dehydration was present.
Bacteriological investigation
All collected stool specimens were tested for Salmonella spp. and
Shigella spp. Fresh stool samples were plated onto Salmonella
Shigella (SS) agar (Difco, Detroit, MI, USA), Hecktoen enteric
(HE) agar (Difco) and xylose lysine deoxycholate (XLD) agar
(Difco) and the plates were incubated for 18–24 h at 37°C.
Approximately 1 g of each sample was inoculated into 10 mL of
selenite F broth (Himedia, Mumbai, India) and the broth was
incubated for 18–24 h at 37°C. After overnight incubation,
approximately 0.5 mL of selenite F broth was subcultured onto SS
agar, HE agar and XLD agar.
Suspected colonies on the primary or subculture plates resem-
bling those of Salmonella and Shigella were selected for further
identification by standard laboratory procedures.13,14
Identification of Salmonella and Shigella
isolates
Isolated bacteria were identified by their biochemical reaction
profile using Hy.enterotest (Hy.laboratories, Jerusalem, Israel) and
the API-20E test kit (bioMerieux, Marcy l’Etoile, France). The
biochemical assays were supplemented with testing for agglutina-
tion using the specific anti-Shigella agglutination sera (Difco) and
anti-Salmonella agglutination sera (Difco).
Antimicrobial susceptibility testing by disk
diffusion
Antibiotic susceptibility of Salmonella and Shigella isolates were
performed by the disk diffusion method according to guidelines
established by the National Committee for Clinical Laboratory
Standards (NCCLS) using Muller–Hinton agar (Sanofi Diagnostic
Pasteur, Marnes-la-Coquette, France). The isolates were tested
against a total of 11 antibiotics, the most common antimicrobial
agents used for children: ampicillin, cephalexin, cefotaxime,
cefuroxime, ceftazidim, ceftriaxone, amikacin, gentamicin,
trimethoprim-sulfamethoxazole, nalidixic acid and
chloramphenicol.15,16
Results
A total of 93 positive bacterial cultures were obtained from 3570
stool samples examined over the period January 1999 to Septem-
ber 2006. In total, 53 of the positive stool cultures were from males
and 40 were from females.
The frequency of isolation was 0.8% (28/3570) for Shigella spp.
and 1.8% (65/3570) for Salmonella spp.
Salmonella spp. were found in 65/93 of the cases (69.9%)
Table 1. Whereas Shigella spp. were found in 28/93 of the cases
(30.1%), with higher frequency of S. flexneri (16/28) compared
with S. sonnei (7/28), S. boydii (4/28) and S. dysenteriae (1/28).
The antimicrobial agents used and the susceptibility results of
the Shigella and Salmonella isolates are shown in Table 2.
Table 1 Bacterial enteropathogens identified in the 93 positive
specimens
Microorganism Number and percentage of positive samples
n %






Total Shigella spp. 28 30.1
Total bacteria 93 100.0
Table 2 Resistance (%) of Shigella and Salmonella strains isolated
from stool of hospitalized children with diarrhea to 11 antibiotics
Antibiotic Bacterial isolates
Shigella Salmonella
(n = 28) Resistance
(%)
(n = 65) Resistance
(%)
Ampicillin 22 79 40 62
Trimethoprim-
sulfamethoxazole
25 89 23 35
Chloramphenicol 13 46 23 35
Cephalexin 3 11 17 26
Cefuroxime 2 7 4 6
Cefotaxime 1 4 1 2
Ceftazidim 1 4 1 2
Ceftriaxone 1 4 1 2
Amikacin 1 4 5 8
Nalidixic acid 1 4 8 12
Gentamicin 2 7 9 14
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Antimicrobial susceptibility testing of Shigella strains showed
that 89% of the isolates were resistant to trimethoprim-
sulfamethoxazole, 79% resistant to ampicillin and 46% resistant to
chloramphenicol (Table 2).
Cefotaxime, ceftazidim, ceftriaxone, amikacin and nalidixic
acid proved to be the most effective drugs against Shigella spp.
Antimicrobial susceptibility testing of Salmonella strains
showed that 62% of the isolates were resistant to ampicillin, 35%
were resistant to trimethoprim-sulfamethoxazole and 35% were
resistant to chloramphenicol, 26% resistant to cephalexin, 14%
resistant to gentamicin and 12% resistant to nalidixic acid. Most
Salmonella isolates were sensitive to cefotaxime, ceftazidim and
ceftriaxone (Table 2).
Discussion
Diarrhea remains one of the most common illnesses of children
and one of the major causes of infant and childhood mortality in
developing countries. Considering the usually scanty resources
available in these countries, a reduction in diarrhea-related mor-
tality may be possible by identifying high-risk subjects and target-
ing them for intensive intervention.
The etiology of diarrhea is multifactorial (viral-parasites and
bacterial pathogens), where viral infection is the most common.
The infections with bacterial pathogens peak during the summer
when there are suitable conditions such as humidity and
high temperature which facilitate the bacterial growth and
dissemination.17,18
In the present study, 65 of the isolates proved positive for
Salmonella spp. and 28 were Shigella spp. Shigella flexneri was
the most common (16/28) among the isolated Shigella, emphasiz-
ing the importance of this pathogen in the epidemiology of child-
hood bacterial diarrhea in Gaza, and indicating that either
S. flexneri is more common in our environment or it is more
associated with severe diarrheal presentations. This finding is con-
sistent with other reports from developing countries such as India,
Bangladesh, Brazil, Tanzania, Egypt and Thailand.19,20
The low detection rate of Salmonella and Shigella might be due
to the delay in ordering stool cultures, since physicians sometimes
ask for stool cultures after >4 days of hospitalization and after
treatment has failed. In 1997, Rohner et al. showed that the recov-
ery rate of Salmonella spp., and Shigella spp. from stool cultures
decreases by more than one-quarter when patients have been hos-
pitalized for >3 days.21
Additionally, antibiotic therapy prior to specimen collection and
delay for >3 h in delivering some of the specimens to the labora-
tory for processing could be responsible for the low yield of
bacterial cultures.
In spite of the relatively small number of positive samples, we
believe that our data provide useful information about the antimi-
crobial resistance of Shigella and Salmonella isolates. In order to
help practitioners choose an adequate antimicrobial drug to start
empiric therapy in a patient with severe diarrhea without knowl-
edge of a specific pathogen, we assessed the antimicrobial resis-
tance patterns of Shigella and Salmonella spp. that could be
isolated. In most pediatric hospitals the empiric antimicrobial
drugs used in the treatment of gastroenteritis and diarrhea patients
is ampicillin, and physicians usually prescribe trimethoprim-
sulfamethoxazole after discharge from the hospital.
The antibiograms of Salmonella and Shigella isolates showed
that the most frequent patterns of resistance were to ampicillin and
to a combination of trimethoprim-sulfamethoxazole and chloram-
phenicol. Cephalexin and gentamicin had low resistance pattern,
whereas most of the isolates were sensitive to cefotaxime, ceftazi-
dim, ceftriaxone, amikacin and nalidixic acid. Several studies have
indicated high resistance of Salmonella and Shigella to ampicillin,
trimethoprim-sulfamethoxazole and chloramphenicol, which is in
agreement with our study.22–24
Shigella is becoming more resistant to commonly used antibi-
otics, especially in the developing countries;25 however, the preva-
lence of resistance to the same antibiotics is lower in developed
countries.26,27 This could be due to the more prudent use usage of
antibiotics in the developed as compared with the developing
countries.
In Gaza, Palestine, there is no published information on the
drug resistance pattern of recent isolates for shigellosis and
salmonellosis.
Multiple antibiotic resistance in bacterial pathogens is now a
common phenomenon in developing countries. This circumstance
is most likely related to the frequent use of over-the-counter drugs
without proper or any medical supervision.12,28
The high resistance of our isolates to trimethoprim-
sulfamethoxazole, chloramphenicol and ampicillin observed may
be because in the primary heath care in Gaza Strip, trimethoprim-
sulfamethoxazole is the most commonly used antimicrobial drug
for the treatment of gastroenteritis and diarrhea, while amoxicillin
is the most frequently prescribed antibiotic for the treatment of
upper respiratory tract infections. As in the developing countries,
ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole
are widely used to treat diarrhea because of their low cost and
ready availability.19
In Palestine, self-medication and purchase of drugs without
prescriptions are common practice. Thus, there is a greater possi-
bility of development of resistant strains due to overuse and misuse
of antibiotics.
Development and use of new drugs are expensive and have
severe limitations in developing countries. Simple prophylactic
alternatives are therefore required, such as awareness of hygienic
childcare practices and early promotion of breast feeding.20,29
A call to regulate the use of antimicrobials may be neces-
sary. According to our study, ampicillin, trimethoprim-
sulfamethoxazole and chloramphenicol should not be used as
empiric treatment of diarrhea in children, or in very severe cases.
With evidence of dissemination of disease, the second- and
third-generation cephalosporins are highly recommended.
In conclusion, the current study highlights the necessity for
continuous monitoring of antibiotic resistance in diarrhea related
to bacterial pathogens, and the need for introducing new methods
for the identification of enteropathogens other than Shigella and
Salmonella. The sensitivity of the isolation could be improved by
using PCR assay.30
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